NeoGenomics: Q1 Earnings Snapshot
By Ap News
Published - Apr 30, 2024, 07:40 AM ET
Last Updated - Apr 30, 2024, 07:40 AM EDT
FORT MYERS, Fla. (AP) — FORT MYERS, Fla. (AP) — NeoGenomics Inc. (NEO) on Tuesday reported a loss of $27.1 million in its first quarter.
On a per-share basis, the Fort Myers, Florida-based company said it had a loss of 21 cents. Losses, adjusted for amortization costs and stock option expense, were 2 cents per share.
The results beat Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 3 cents per share.
The operator of cancer-focused testing laboratories posted revenue of $156.2 million in the period, also surpassing Street forecasts. Six analysts surveyed by Zacks expected $149.8 million.
